Cargando…
The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer
The present study aims to evaluate the pretherapeutic Fibrinogen-Albumin-Ratio Index (FARI), as currently reliable biomarkers to predict therapy response and prognosis of patients with advanced vulvar cancer are missing. Data of 124 consecutive patients, who underwent primary resection for vulvar ca...
Autores principales: | Onoprienko, Arina, Hofstetter, Gerda, Dorittke, Tim, Bekos, Christine, Grimm, Christoph, Polterauer, Mariella, Bartl, Thomas, Polterauer, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694316/ https://www.ncbi.nlm.nih.gov/pubmed/36579608 http://dx.doi.org/10.3390/jpm12111882 |
Ejemplares similares
-
Fibrinogen–Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy
por: Guo, Ziwei, et al.
Publicado: (2021) -
Prognostic value of the fibrinogen albumin ratio index (FARI) in nasopharyngeal carcinoma patients undergoing radiotherapy
por: Deng, Chao, et al.
Publicado: (2023) -
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients
por: Bartl, Thomas, et al.
Publicado: (2021) -
Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma – a multicenter study
por: Bekos, Christine, et al.
Publicado: (2017) -
The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)